Literature DB >> 25695144

Ice water submersion for rapid cooling in severe drug-induced hyperthermia.

Larissa K Laskowski1, Adaira Landry, Susi U Vassallo, Robert S Hoffman.   

Abstract

CONTEXT: The optimal method of cooling hyperthermic patients is controversial. Although controlled data support ice water submersion, many authorities recommend a mist and fan technique. We report two patients with drug-induced hyperthermia, to demonstrate the rapid cooling rates of ice water submersion. CASE DETAILS: Case 1. A 27-year-old man presented with a sympathomimetic toxic syndrome and a core temperature of 41.4°C after ingesting 4-fluoroamphetamine. He was submerged in ice water and his core temperature fell to 38°C within 18 minutes (a mean cooling rate of 0.18°C/min). His vital signs stabilized, his mental status improved and he left on hospital day 2. Case 2. A 32-year-old man with a sympathomimetic toxic syndrome after cocaine use was transported in a body bag and arrived with a core temperature of 44.4°C. He was intubated, sedated with IV benzodiazepines, and submerged in ice water. After 20 mins his temperature fell to 38.8°C (a cooling rate of 0.28°C/min). He was extubated the following day, and discharged on day 10. DISCUSSION: In these two cases, cooling rates exceeded those reported for mist and fan technique. Since the priority in hyperthermia is rapid cooling, clinical data need to be collected to reaffirm the optimal approach.

Entities:  

Keywords:  Amphetamine; Cooling; Heat stroke; Hyperthermia; Sympathomimetic toxic syndrome

Mesh:

Substances:

Year:  2015        PMID: 25695144      PMCID: PMC4684641          DOI: 10.3109/15563650.2015.1009994

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  8 in total

1.  Endovascular hypothermia for heat stroke: a case report.

Authors:  Bruno Mégarbane; Dabor Résière; Arnaud Delahaye; Frédéric J Baud
Journal:  Intensive Care Med       Date:  2003-11-05       Impact factor: 17.440

Review 2.  Heat stroke.

Authors:  Abderrezak Bouchama; James P Knochel
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

3.  Whole-body cooling of hyperthermic runners: comparison of two field therapies.

Authors:  L E Armstrong; A E Crago; R Adams; W O Roberts; C M Maresh
Journal:  Am J Emerg Med       Date:  1996-07       Impact factor: 2.469

4.  Effect of water temperature on cooling efficiency during hyperthermia in humans.

Authors:  C I Proulx; M B Ducharme; G P Kenny
Journal:  J Appl Physiol (1985)       Date:  2002-11-27

5.  A physiological body-cooling unit for treatment of heat stroke.

Authors:  J S Weiner; M Khogali
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

6.  Heat stroke: report on 18 cases.

Authors:  M Khogali; J S Weiner
Journal:  Lancet       Date:  1980-08-09       Impact factor: 79.321

7.  Helicopter cooling of heatstroke victims.

Authors:  T J Poulton; R A Walker
Journal:  Aviat Space Environ Med       Date:  1987-04

Review 8.  Cooling and hemodynamic management in heatstroke: practical recommendations.

Authors:  Abderrezak Bouchama; Mohammed Dehbi; Enrique Chaves-Carballo
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  8 in total
  3 in total

1.  4-Fluoroamphetamine in Serum and Urine from an Intoxicated Patient with Life-Threatening Hyperpyrexia.

Authors:  Justin L Poklis; Carl E Wolf; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2016-01-18       Impact factor: 3.367

Review 2.  Haemorrhagic stroke related to the use of 4-fluoroamphetamine.

Authors:  C H W Wijers; M C Visser; R T H van Litsenburg; R J M Niesink; R B Willemse; Esther A Croes
Journal:  J Neurol       Date:  2018-05-08       Impact factor: 4.849

3.  4-Fluoroamphetamine (4-FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis.

Authors:  Femke M J Gresnigt; Anouk Snik; Eric J F Franssen; Joost W Vanhommerig; Dylan W de Lange; Robert K Riezebos
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.